APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 130 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16 | -57.9% | 419 | 0.0% | 0.00% | – |
Q2 2023 | $38 | +31.0% | 419 | -5.8% | 0.00% | – |
Q1 2023 | $29 | +26.1% | 445 | 0.0% | 0.00% | – |
Q4 2022 | $23 | -99.9% | 445 | +12.1% | 0.00% | – |
Q3 2022 | $27,000 | +50.0% | 397 | 0.0% | 0.00% | – |
Q2 2022 | $18,000 | +20.0% | 397 | +33.2% | 0.00% | – |
Q1 2022 | $15,000 | +7.1% | 298 | 0.0% | 0.00% | – |
Q4 2021 | $14,000 | +40.0% | 298 | 0.0% | 0.00% | – |
Q3 2021 | $10,000 | 0.0% | 298 | +87.4% | 0.00% | – |
Q2 2021 | $10,000 | +42.9% | 159 | 0.0% | 0.00% | – |
Q1 2021 | $7,000 | -12.5% | 159 | +12.0% | 0.00% | – |
Q4 2020 | $8,000 | -38.5% | 142 | -66.1% | 0.00% | – |
Q3 2020 | $13,000 | +18.2% | 419 | 0.0% | 0.00% | – |
Q2 2020 | $11,000 | 0.0% | 419 | 0.0% | 0.00% | – |
Q1 2020 | $11,000 | 0.0% | 419 | +16.1% | 0.00% | – |
Q4 2019 | $11,000 | +10.0% | 361 | -9.3% | 0.00% | – |
Q3 2019 | $10,000 | 0.0% | 398 | 0.0% | 0.00% | – |
Q2 2019 | $10,000 | +42.9% | 398 | +11.2% | 0.00% | – |
Q1 2019 | $7,000 | 0.0% | 358 | -28.4% | 0.00% | – |
Q4 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |